Last reviewed · How we verify

Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules

Western University, Canada · Phase 1 active Biologic Quality 0/100

Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules is a Biologic drug developed by Western University, Canada. It is currently in Phase 1 development.

At a glance

Generic nameLactobacillus GR-1 and Lactobacillus RC-14 oral capsules
SponsorWestern University, Canada
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules

What is Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules?

Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules is a Biologic drug developed by Western University, Canada.

Who makes Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules?

Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules is developed by Western University, Canada (see full Western University, Canada pipeline at /company/western-university-canada).

What development phase is Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules in?

Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules is in Phase 1.

Related